| Dr Jennifer I Giesige, DO | |
|
430 E Division St, Fond Du Lac, WI 54935-4560 | |
| (920) 929-2300 | |
| Not Available |
| Full Name | Dr Jennifer I Giesige |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 14 Years |
| Location | 430 E Division St, Fond Du Lac, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235450461 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 66482-21 (Wisconsin) | Primary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | PG151470 (Oregon) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Agnes Hospital | Fond du lac, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Agnesian Healthcare Inc | 1658289624 | 319 |
News Archive
The pain from hammertoe, a deformity that can cause one or more toes to assume a claw shape, can curtail an evening of dancing or make a favorite pair of shoes unwearable. But, according to the June issue of Mayo Clinic Health Letter, this condition often can be managed by proper footwear or simple toe coverings.
New research from the University of Sydney has found poisoning exposures in children and adolescents while at school are relatively common and appear to be increasing, highlighting the need for more robust prevention measures.
"Chile launched a hepatitis and tetanus vaccination campaign Friday and doctors warned of outbreaks of diarrhea and infection among thousands of people displaced by the earthquake and the tsunami that heavily damaged or destroyed 36 hospitals and made garbage dumps of coastal towns and cities," the Associated Press reports. So far, no dysentery outbreaks or other communicable diseases had been reported, Chile's health ministry said, adding that it believed it had adequate amounts of tetanus and hepatitis vaccinations.
Boston Scientific Corporation today announced that it has enrolled the first patient in its TAXUS Liberte post-approval study. The study is designed to evaluate real-world clinical outcomes data for the TAXUS® Liberte® Paclitaxel-Eluting Coronary Stent System in combination with a dual antiplatelet therapy drug regimen that includes aspirin and Effient®, a new antiplatelet medication. Co-sponsors of the study include Eli Lilly and Company and Daiichi Sankyo, Inc., manufacturers of Effient, which was recently approved by the U.S. Food and Drug Administration (FDA).
› Verified 1 days ago
| Entity Name | Agnesian Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346228541 PECOS PAC ID: 1658289624 Enrollment ID: O20031104000263 |
News Archive
The pain from hammertoe, a deformity that can cause one or more toes to assume a claw shape, can curtail an evening of dancing or make a favorite pair of shoes unwearable. But, according to the June issue of Mayo Clinic Health Letter, this condition often can be managed by proper footwear or simple toe coverings.
New research from the University of Sydney has found poisoning exposures in children and adolescents while at school are relatively common and appear to be increasing, highlighting the need for more robust prevention measures.
"Chile launched a hepatitis and tetanus vaccination campaign Friday and doctors warned of outbreaks of diarrhea and infection among thousands of people displaced by the earthquake and the tsunami that heavily damaged or destroyed 36 hospitals and made garbage dumps of coastal towns and cities," the Associated Press reports. So far, no dysentery outbreaks or other communicable diseases had been reported, Chile's health ministry said, adding that it believed it had adequate amounts of tetanus and hepatitis vaccinations.
Boston Scientific Corporation today announced that it has enrolled the first patient in its TAXUS Liberte post-approval study. The study is designed to evaluate real-world clinical outcomes data for the TAXUS® Liberte® Paclitaxel-Eluting Coronary Stent System in combination with a dual antiplatelet therapy drug regimen that includes aspirin and Effient®, a new antiplatelet medication. Co-sponsors of the study include Eli Lilly and Company and Daiichi Sankyo, Inc., manufacturers of Effient, which was recently approved by the U.S. Food and Drug Administration (FDA).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jennifer I Giesige, DO 420 E Division St, Fond Du Lac, WI 54935-4560 Ph: (920) 926-8343 | Dr Jennifer I Giesige, DO 430 E Division St, Fond Du Lac, WI 54935-4560 Ph: (920) 929-2300 |
News Archive
The pain from hammertoe, a deformity that can cause one or more toes to assume a claw shape, can curtail an evening of dancing or make a favorite pair of shoes unwearable. But, according to the June issue of Mayo Clinic Health Letter, this condition often can be managed by proper footwear or simple toe coverings.
New research from the University of Sydney has found poisoning exposures in children and adolescents while at school are relatively common and appear to be increasing, highlighting the need for more robust prevention measures.
"Chile launched a hepatitis and tetanus vaccination campaign Friday and doctors warned of outbreaks of diarrhea and infection among thousands of people displaced by the earthquake and the tsunami that heavily damaged or destroyed 36 hospitals and made garbage dumps of coastal towns and cities," the Associated Press reports. So far, no dysentery outbreaks or other communicable diseases had been reported, Chile's health ministry said, adding that it believed it had adequate amounts of tetanus and hepatitis vaccinations.
Boston Scientific Corporation today announced that it has enrolled the first patient in its TAXUS Liberte post-approval study. The study is designed to evaluate real-world clinical outcomes data for the TAXUS® Liberte® Paclitaxel-Eluting Coronary Stent System in combination with a dual antiplatelet therapy drug regimen that includes aspirin and Effient®, a new antiplatelet medication. Co-sponsors of the study include Eli Lilly and Company and Daiichi Sankyo, Inc., manufacturers of Effient, which was recently approved by the U.S. Food and Drug Administration (FDA).
› Verified 1 days ago
Michael J Keyes, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 430 E Division St, Fond Du Lac, WI 54935 Phone: 920-926-4200 Fax: 920-926-8885 | |
Dr. Steven A Sandstrom, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 210 Wisconsin American Dr, Fond Du Lac, WI 54937 Phone: 920-907-7000 Fax: 920-907-7110 | |
Jagadeeswara Rao Musunuru, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 459 E 1st St, Fond Du Lac, WI 54935 Phone: 920-929-3502 | |
Shelley D Piasecki, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 751 County Road K, Fond Du Lac, WI 54937 Phone: 920-929-6716 | |
Cheryl R Tapp, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 430 E Division St, Fond Du Lac, WI 54935 Phone: 920-926-4200 Fax: 920-926-8885 | |
Brian C Christenson, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 430 E Division St, Fond Du Lac, WI 54935 Phone: 920-926-4200 Fax: 920-926-8885 |